APOC3 and Wilson disease: However, in the jejunum, the level of Apoc3 mRNA expression (inhibitor of LPL) was significantly decreased in inulin-treated groups (main effect p-value treatment < 0.05) whereas the level of Apoc2 (activator of LPL) was increased in WD groups (main effect p-value diet < 0.05).